Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus
Baek, W.-Y.; Choi, Y.-S.; Lee, S.-W.; Son, I.-O.; Jeon, K.-W.; Choi, S.-D.; Suh, C.-H. Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2021, 22, 12764. https://doi.org/10.3390/ijms222312764
Baek W-Y, Choi Y-S, Lee S-W, Son I-O, Jeon K-W, Choi S-D, Suh C-H. Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2021; 22(23):12764. https://doi.org/10.3390/ijms222312764
Chicago/Turabian StyleBaek, Wook-Young, Yang-Seon Choi, Sang-Won Lee, In-Ok Son, Ki-Woong Jeon, Sang-Dun Choi, and Chang-Hee Suh. 2021. "Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus" International Journal of Molecular Sciences 22, no. 23: 12764. https://doi.org/10.3390/ijms222312764